November 2022 in “Journal of Education, Health and Sport” This review discusses various pharmacotherapies for androgenetic alopecia, concluding that combination therapies may offer more effective treatment, though more research on alternative preparations is needed.
2 citations
,
September 2022 in “American Journal of Clinical Dermatology” September 2022 in “IP Indian journal of clinical and experimental dermatology” This review discusses treatments for androgenetic alopecia, recommending Minoxidil, Finasteride, and Dutasteride as first-line therapies, and highlights the potential of JAK inhibitors for future permanent cures.
1 citations
,
August 2022 in “Journal of Dermatological Treatment” In this study, the authors reported that oral dutasteride at 0.5 mg/day showed a probable greater efficacy in treating male androgenetic alopecia compared to finasteride and minoxidil, but it may cause sexual dysfunction and neuropsychiatric side effects.
August 2021 in “Skin appendage disorders” This case report highlights two instances of patchy alopecia occurring after mesotherapy with dutasteride, illustrating a possible paradoxical side effect of this treatment for androgenetic alopecia.
3 citations
,
May 2020 in “Journal of The Korean Medical Association” This review discusses treatment options for androgenetic alopecia, with a focus on the better efficacy of oral finasteride and dutasteride over topical minoxidil for male pattern hair loss, but it reports no new clinical results.
1 citations
,
August 2018 in “Journal of The American Academy of Dermatology” Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.
54 citations
,
May 2018 in “Journal of The European Academy of Dermatology and Venereology” This study found that low-level laser therapy was the most effective non-surgical treatment for androgenetic alopecia, although the overall quality of evidence supporting various therapies was generally low.
6 citations
,
April 2016 in “PubMed” This review found that dutasteride and finasteride are rarely associated with sexual side effects when used off-label for female hair loss, and suggests further study of their efficacy and side effect profile.
100 citations
,
April 2010 in “Expert Opinion on Pharmacotherapy” This article reviews existing treatments for male-pattern hair loss, noting that while they can slow progression, they generally achieve only partial hair regrowth.